Investor Alert

New York Markets Open in:

press release

April 7, 2022, 8:55 a.m. EDT

Next Super Stocks on the Move: ORAGIN Foods, NexTech AR, PharmaDrug, and NuRAN Wireless; Leading Innovation in Metaverse, Plant-Based Brands, Biopharma, and Connectivity

NEW YORK, April 07, Apr 07, 2022 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK investor conferences, which engage an estimated 12 million investors globally each year.

Wall Street Reporter's NEXT SUPER STOCK conferences feature disruptive innovation leaders with +10X upside potential. These emerging growth companies are pursuing multi-billion dollar market opportunities, and are at a key inflection point in their growth trajectory - with multiple catalysts in-place to drive transformational growth, and shareholder value. This selective focus on ultra high-potential leaders, has already delivered eight 10X-50X wins in the past 20 months.

NexTech AR Solutions /zigman2/quotes/205685878/delayed NEXCF -8.75% /zigman2/quotes/208196573/delayed CA:NTAR -6.93% CEO Evan Gappelberg: "NexTech is On-Ramp to Metaverse & Web 3.0 for $5.5 Trillion E-Commerce Market"
NexTech AR /zigman2/quotes/205685878/delayed NEXCF -8.75% , a featured presenter at Wall Street Reporter's "Next Super Stock" investor conference series, recently shared with investors how NEXCF is emerging as a key player in the $5.5 trillion global e-commerce market transition to web 3.0 and the metaverse. NEXCF Augmented Reality solutions enable to view products in lifelike 3D, in their own living room. This AR shopping experience bridges the gap between the physical world, and what was once a flat 2D online e-commerce experience. NEXCFs AR shopping experience is a "game changer" for the 5.5 trillion global e-commerce industry (source:Statisa 2022).

NEXCF AR solutions create billions of dollars in potential profitability and cost cost-savings for e-commerce leaders by driving +93% increases in click through rate, and -40% reductions in product returns. This value creation and ROI is driving growing demand and industry adoption of NEXCF AR solutions. Nearly 2 billion of the world's population now shops online. Most importantly, over 72% of e-commerce is now done by mobile phone - a native platform for Augmented Reality apps like NEXCF. Global blue chip brands utilizing NexTech AR, include: Ford Mach EV, Kohls, CB2, Crate & Barrel, Pier 1, and Segway.

"NexTech's AR solutions are rapidly becoming a 'must-have' for e-commerce leaders to succeed in today's hyper-competitive market, where even marginal improvements in metrics like click-though and return-rates can mean the difference of billions of dollars to a company's bottom line...We're at an inflection point now, where industry demand and adoption for NexTech's AR is accelerating and going mainstream. As E-Commerce shifts to Web 3.0 and the Metaverse, the demand for AR/3D product models becomes essential. NexTech is emerging as the "on ramp" to the Metaverse and Web 3.0 for the $5.5 trillion e-commerce industry. With over 200 million product SKU's in e-commerce worldwide - NexTech has a potential revenue pipeline worth billions of dollars in coming years."

Watch NEXT SUPER STOCK /zigman2/quotes/205685878/delayed NEXCF -8.75% /zigman2/quotes/208196573/delayed CA:NTAR -6.93% Video: https://www.wallstreetreporter.com/2022/04/06/next-super-stock-nextech-ar-otc-nexcf-cse-ntar-on-ramp-to-metaverse-web-3-0-for-5-trillion-e-commerce-market/

ORAGIN Foods /zigman2/quotes/225150188/composite OGGFF +3.89% (tsx.v:OG) CEO Matt Lurie: "Ready to Scale with Plant-Based Brands and Next Gen Organic Retailing"
ORAGIN Foods /zigman2/quotes/225150188/composite OGGFF +3.89% a featured presenter at Wall Street Reporter's NEXT SUPER STOCK investor conference, is capitalizing on twin megatrends in the booming plant-based foods space and specialty organic retailing. In his recent presentation, OGGFF CEO Matt Lurie shared with investors how OGGFF is positioned for explosive growth in the coming months, as it scales its "Organic Garage" specialty retail stores and expands its portfolio of CPG brands focusing on the plant-based and organic lifestyle.

Watch ORAGIN Foods /zigman2/quotes/225150188/composite OGGFF +3.89% /zigman2/quotes/205617165/delayed CA:OG +9.09% Next Super Stock livestream video: https://www.wallstreetreporter.com/2022/03/01/oragin-foods-otc-oggff-tsx-og-unleashes-30x-upside-potential/

OGGFF's "Organic Garage" specialty retail stores have built up a cult following among millennial shoppers in Toronto, Canada through a fun experiential retail concept and discount pricing - "Healthier Food For Less". OGGFF currently has four stores generating over $30 million in revenue, at strong gross margins - and is now at an inflection point - ready to scale rapidly with new locations. In his interview with Wall Street Reporter, OGGFF CEO Matt Lurie discusses the possibilities for scaling the Organic Garage brand globally, whether through company owned stores, partnerships, and or franchises.

CEO Matt Lurie is especially excited about the growth potential for OGGFF's branded CPG (Consumer Packaged Goods) business focused on the $30 billion plant-based foods and lifestyle sector. OGGFF is leveraging its retailing domain expertise into the plant-based foods space. With a strong insight and data on what sells on retail shelves and what today's consumers want, OGGFF is developing a suite of plant-based CPG brands through acquisitions, and internal development with a significant focus on expansion in the US market.

One of OGGFF's recently launched CPG brands "Future of Cheese" (targeting the $900 billion dairy alternatives market) is already gaining significant traction. Developed by the world's leading cheese experts, Future of Cheese is rolling out a full line of cheese, butter and other exciting plant-based dairy products. The brand is a hit with consumers and products are selling out on shelves weekly. OGGFF is now expanding it's product portfolio to 8-10 SKU's in coming months which will help drive market penetration with international retailers, and restaurants. OGGFF expects significant revenue growth potential as it further develops a diversified suite of synergistic CPG brands through acquisitions in coming months.

Watch ORAGIN Foods /zigman2/quotes/225150188/composite OGGFF +3.89% /zigman2/quotes/205617165/delayed CA:OG +9.09% Next Super Stock livestream video: https://www.wallstreetreporter.com/2022/03/01/oragin-foods-otc-oggff-tsx-og-unleashes-30x-upside-potential/

March 23 - OGGFF appoints Matthew Merson to the Company's Advisory Board to support growth and expansion of the Company's Consumer Packaged Goods ("CPG") division. Mr. Merson is an industry executive with over 30 years of leadership roles with some of the most recognized food and beverage brands including dairy giant Danone, Coca-Cola, Glaceau, sustainable water brand Boxed Water, leading coconut water brand ZICO, and most recently, plant-based poultry company Simulate, owner of the popular brand NUGGS. Under Mr. Merson's sales leadership, Simulate has obtained listings in over 10,000 U.S. stores including Walmart, Target, Safeway and Kroger.

April 6 - OGGFF receives FDA registration, allowing the company's Future of Cheese CPG brands, to commence production and sales plans within the U.S. market. The U.S. packaged foods industry is estimated at over $1 trillion in annual sales, according to GrandView Research.

PharmaDrug /zigman2/quotes/205957522/delayed LMLLF +13.19% /zigman2/quotes/207831516/delayed CA:PHRX 0.00% CEO Dan Cohen: "Advancing Drug Pipeline Addressing Billion Dollar Markets"
PharmaDrug /zigman2/quotes/205957522/delayed LMLLF +13.19% /zigman2/quotes/207831516/delayed CA:PHRX 0.00% CEO Dan Cohen, a featured presenter at Wall Street Reporter's NEXT SUPER STOCK investors conference is advancing a pipeline of natural based drugs, addressing multi-billion dollar market opportunities in cancers, anti-viral and glaucoma indications. LMLLF now has four drug candidates advancing towards clinical trials, with key milestones in the weeks ahead.

Watch NEXT SUPER STOCK PharmaDrug /zigman2/quotes/205957522/delayed LMLLF +13.19% /zigman2/quotes/207831516/delayed CA:PHRX 0.00% Video: https://www.wallstreetreporter.com/2022/03/31/next-super-stock-pharmadrug-otc-lmllf-cse-phrx-advancing-biopharm-assets-w-billion-dollar-markets/

LMLLF's flagship platform is PD-001 - a reformulated and patented version of cepharanthine, with lab data demonstrating potential therapies for a number of anti-cancer and anti-viral indications. Cepharanthine is a natural based drug already approved in Japan, with a 70 year history of use. Cepharanthine has shown in studies to both stop the spread and kill cancer cells, and reduce resistance to chemotherapy.

LMLLF's PD-001 is a reformulation of the traditional treatment in pill form used in Japan, but with 10X the bioavailability. LMLLF sees it's PD-001 as a platform for potentially treating a wider array of cancer indications.

LMLLF is now advancing studies for PD-001 for treating esophageal, and prostate cancers. LMLLF has just received FDA Orphan Drug Designation for PD-001 for esophageal cancer a $1.5 billion market opportunity. Orphan Drug Designation allows for potentially fast track FDA approval, lower development costs and increased market protection. LMLLF is also advancing PD-001 for prostate cancer, filing a provisional patent for cepharanthine combined with chemo for prostate cancer.

LMLLF is also developing a treatment for glaucoma, based on a re-formulation of DMT (N-Dimethyltryptamine) to reduce intraocular pressure. Tryptamines, including DMT, have been shown in clinical studies to reduce intraocular pressure. LMLLF is collaborating with the Terasaki Institute for Biomedical Innovation, a world class leader in development of novel drug delivery technologies to optimize DMT formulation with a controlled release device. LMLLF's clinical research has developed two potential drug formulations, which have tested well for low toxicity, and show promising potency and efficacy, and expects to initiate FDA clinical trials in coming months. In his interview, CEO Dan Cophen also shares that LMLLF's pipeline assets have significant upside potential as biotech valuations recover from current cyclical lows.

March 9 - LMLLF reports positive interim findings for combination of Cepharanthine and frontline chemotherapy for IND-enabling prostate cancer study. The study demonstrated improved tumor growth inhibition by 73% compared to cabazitaxel-alone.

Feb 23 - LMLLF receives encouraging potency data for candidate DMT-analogue molecules designed to treat primary open angle glaucoma. LMLLF successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for the treatment of primary open angle glaucoma (POAG). LMLLF intends to use the current results in combination with several planned upcoming in vitro studies to elect its final development candidate. Future in vivo efficacy testing in an accepted model of POAG is currently being planned with the goal of providing all necessary support to file an investigative new drug (IND) application with the FDA to conduct clinical studies.

Feb 1 - LMLLF files a US provisional patent application for Cepharanthine to Treat Prostate Cancer. The provisional patent application details the novel synergistic combination of cepharanthine (PD-001) and cabazitaxel on prostate cancer growth inhibition and also sets forth claims related to the use of PD-001, cabazitaxel and/or other taxane family members used in combination to treat primary, metastatic and chemotherapy-resistant prostate cancer.

Watch NEXT SUPER STOCK PharmaDrug /zigman2/quotes/205957522/delayed LMLLF +13.19% /zigman2/quotes/207831516/delayed CA:PHRX 0.00% Video: https://www.wallstreetreporter.com/2022/03/31/next-super-stock-pharmadrug-otc-lmllf-cse-phrx-advancing-biopharm-assets-w-billion-dollar-markets/

NuRAN Wireless /zigman2/quotes/200473203/delayed NRRWF +2.90% /zigman2/quotes/204173112/delayed CA:NUR -5.06% CEO Francis Letourneau: "Bringing Wireless Connectivity to Africa is Billion Dollar Opportunity for NuRAN"
NuRAN Wireless /zigman2/quotes/200473203/delayed NRRWF +2.90% /zigman2/quotes/204173112/delayed CA:NUR -5.06% CEO Francis Letourneau, a featured presenter at Wall Street Reporter's NEXT SUPER STOCK investors livestream is bringing wireless connectivity to Africa, enabling communications and internet for the last great untapped market of over 1 billion population. Francis shares how NRRWF's contracts with blue chip global telecom partners, position the company on path for over $220 million in annual recurring revenue, and potential billion dollar market valuation in the coming years.

Watch NuRAN Wireless /zigman2/quotes/200473203/delayed NRRWF +2.90% /zigman2/quotes/204173112/delayed CA:NUR -5.06% NEXT SUPER STOCK video:
https://www.wallstreetreporter.com/2022/02/16/next-super-stock-nuran-wireless-otc-nrrwf-path-to-billion-valuation-w-africa-telecom-contract/

NRRWF provides telecom operators in Africa a turnkey "Network as a Service" (NaaS) infrastructure solution, specializing in rural and remote areas. NRRWF has developed carrier-grade mobile networks, and towers using solar power that are ideally suited for rural and remote environments in developing economies such as Africa where 300 million people have zero mobile coverage. Mobile connectivity in the developing world is a vital lifeline for healthcare, jobs, trade and education. NRRWF currently has contracts in place with blue chip telcom's like Orange S.A. for services in Cameroon, Democratic Republic of Congo, and with MTN Group in South Sudan for 2,492 sites, which it is now rolling out. These initial 10 year contracts are expected to generate $50 million annual revenues with EBITDA of 50%.

NRRWF plans to roll out to at least 10,000 mobile telecom sites in Africa over the next 5 years, which is expected to generate $220 million annual revenues with $110 million EBITDA. At typical multiples in the sector, this could value NRRWF at over $1 billion.

NRRWF has a pipeline of about 15,000 potential sites in Africa, and is also targeting similar contracts in Latin America and the Asia Pacific region. NRRWF is now in the early stages of its deployment, with a long runway of growth in the months ahead.

Watch NuRAN Wireless /zigman2/quotes/200473203/delayed NRRWF +2.90% /zigman2/quotes/204173112/delayed CA:NUR -5.06% NEXT SUPER STOCK video: https://www.wallstreetreporter.com/2022/02/16/next-super-stock-nuran-wireless-otc-nrrwf-path-to-billion-valuation-w-africa-telecom-contract/

WALL STREET REPORTER

Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com . Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: https://tinyurl.com/2x4eznd5

About Wall Street Reporter's Next Super Stock conference:

Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/

CONTACT:

WALL STREET REPORTER

(212) 871-2057 ext 7

www.WallStreetReporter.com

COMTEX_405362438/2471/2022-04-07T08:54:39

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2022 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/205685878/delayed
US : U.S.: OTC
$ 0.73
-0.07 -8.75%
Volume: 216,330
Aug. 12, 2022 3:57p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$73.18 million
Rev. per Employee
$123,757
loading...
/zigman2/quotes/208196573/delayed
CA : Canadian Securities Exchange
$ 0.94
-0.07 -6.93%
Volume: 104,900
Aug. 12, 2022 3:58p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$93.66 million
Rev. per Employee
$154,947
loading...
/zigman2/quotes/205685878/delayed
US : U.S.: OTC
$ 0.73
-0.07 -8.75%
Volume: 216,330
Aug. 12, 2022 3:57p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$73.18 million
Rev. per Employee
$123,757
loading...
/zigman2/quotes/205685878/delayed
US : U.S.: OTC
$ 0.73
-0.07 -8.75%
Volume: 216,330
Aug. 12, 2022 3:57p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$73.18 million
Rev. per Employee
$123,757
loading...
/zigman2/quotes/208196573/delayed
CA : Canadian Securities Exchange
$ 0.94
-0.07 -6.93%
Volume: 104,900
Aug. 12, 2022 3:58p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$93.66 million
Rev. per Employee
$154,947
loading...
/zigman2/quotes/225150188/composite
US : U.S.: OTC
$ 0.09
+0.0035 +3.89%
Volume: 1,550
Aug. 12, 2022 2:48p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$5.80 million
Rev. per Employee
$155,885
loading...
/zigman2/quotes/225150188/composite
US : U.S.: OTC
$ 0.09
+0.0035 +3.89%
Volume: 1,550
Aug. 12, 2022 2:48p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$5.80 million
Rev. per Employee
$155,885
loading...
/zigman2/quotes/225150188/composite
US : U.S.: OTC
$ 0.09
+0.0035 +3.89%
Volume: 1,550
Aug. 12, 2022 2:48p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$5.80 million
Rev. per Employee
$155,885
loading...
/zigman2/quotes/205617165/delayed
CA : Canada: TSX Venture
$ 0.12
+0.01 +9.09%
Volume: 77,210
Aug. 12, 2022 3:11p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$7.42 million
Rev. per Employee
$195,438
loading...
/zigman2/quotes/225150188/composite
US : U.S.: OTC
$ 0.09
+0.0035 +3.89%
Volume: 1,550
Aug. 12, 2022 2:48p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$5.80 million
Rev. per Employee
$155,885
loading...
/zigman2/quotes/205617165/delayed
CA : Canada: TSX Venture
$ 0.12
+0.01 +9.09%
Volume: 77,210
Aug. 12, 2022 3:11p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$7.42 million
Rev. per Employee
$195,438
loading...
/zigman2/quotes/205957522/delayed
US : U.S.: OTC
$ 0.03
+0.0031 +13.19%
Volume: 32,293
Aug. 12, 2022 1:21p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$8.28 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207831516/delayed
CA : Canadian Securities Exchange
$ 0.03
0.00 0.00%
Volume: 236,084
Aug. 12, 2022 1:50p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$10.60 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/205957522/delayed
US : U.S.: OTC
$ 0.03
+0.0031 +13.19%
Volume: 32,293
Aug. 12, 2022 1:21p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$8.28 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207831516/delayed
CA : Canadian Securities Exchange
$ 0.03
0.00 0.00%
Volume: 236,084
Aug. 12, 2022 1:50p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$10.60 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/205957522/delayed
US : U.S.: OTC
$ 0.03
+0.0031 +13.19%
Volume: 32,293
Aug. 12, 2022 1:21p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$8.28 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207831516/delayed
CA : Canadian Securities Exchange
$ 0.03
0.00 0.00%
Volume: 236,084
Aug. 12, 2022 1:50p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$10.60 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/205957522/delayed
US : U.S.: OTC
$ 0.03
+0.0031 +13.19%
Volume: 32,293
Aug. 12, 2022 1:21p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$8.28 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207831516/delayed
CA : Canadian Securities Exchange
$ 0.03
0.00 0.00%
Volume: 236,084
Aug. 12, 2022 1:50p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$10.60 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/200473203/delayed
US : U.S.: OTC
$ 0.64
+0.02 +2.90%
Volume: 2,000
Aug. 12, 2022 9:30a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$18.59 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/204173112/delayed
CA : Canadian Securities Exchange
$ 0.75
-0.04 -5.06%
Volume: 34,035
Aug. 12, 2022 3:58p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$23.79 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/200473203/delayed
US : U.S.: OTC
$ 0.64
+0.02 +2.90%
Volume: 2,000
Aug. 12, 2022 9:30a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$18.59 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/204173112/delayed
CA : Canadian Securities Exchange
$ 0.75
-0.04 -5.06%
Volume: 34,035
Aug. 12, 2022 3:58p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$23.79 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/200473203/delayed
US : U.S.: OTC
$ 0.64
+0.02 +2.90%
Volume: 2,000
Aug. 12, 2022 9:30a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$18.59 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/204173112/delayed
CA : Canadian Securities Exchange
$ 0.75
-0.04 -5.06%
Volume: 34,035
Aug. 12, 2022 3:58p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$23.79 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/200473203/delayed
US : U.S.: OTC
$ 0.64
+0.02 +2.90%
Volume: 2,000
Aug. 12, 2022 9:30a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$18.59 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/204173112/delayed
CA : Canadian Securities Exchange
$ 0.75
-0.04 -5.06%
Volume: 34,035
Aug. 12, 2022 3:58p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$23.79 million
Rev. per Employee
N/A
loading...

Partner Center

Link to MarketWatch's Slice.